Drug could potentially prevent respiratory and cardiovascular damage in Covid-19 patients

A mutation in all SARS-CoV-2 variants results in significant damage to the lung tissue and blood vessels, RCSI research

Scientists have identified a drug that can prevent the virus that causes COVID-19 from binding to human cells, potentially preventing damage to the lung, clot formation and the development of sepsis.